Journal article
Association of ketamine with psychiatric symptoms andimplications forits therapeutic use and for understanding schizophrenia: A systematic review and meta-analysis
- Abstract:
-
Importance Ketamine hydrochloride is increasingly used to treat depression and other psychiatric disorders but can induce schizophrenia-like or psychotomimetic symptoms. Despite this risk, the consistency and magnitude of symptoms induced by ketamine or what factors are associated with these symptoms remain unknown.
Objective To conduct a meta-analysis of the psychopathological outcomes associated with ketamine in healthy volunteers and patients with s... Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, 1.5MB, Terms of use)
-
- Publisher copy:
- 10.1001/jamanetworkopen.2020.4693
Authors
- Publisher:
- American Medical Association
- Journal:
- JAMA Network Open More from this journal
- Volume:
- 3
- Issue:
- 5
- Article number:
- e204693
- Publication date:
- 2020-05-21
- Acceptance date:
- 2020-02-29
- DOI:
- EISSN:
-
2574-3805
- Pmid:
-
32437573
- Language:
-
English
- Keywords:
- Pubs id:
-
1106702
- Local pid:
-
pubs:1106702
- Deposit date:
-
2021-03-04
Terms of use
- Copyright holder:
- K Beck et al.
- Copyright date:
- 2020
- Rights statement:
- This is an open access article distributed under the terms of the CC-BY License. © 2020 Beck K et al. JAMA Network Open.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record